ATE234341T1 - Dreidimensionale struktur enthaltend hyaluronsäurederivat, hergestellt durch die technik von superkritischen antilösungsmitteln - Google Patents
Dreidimensionale struktur enthaltend hyaluronsäurederivat, hergestellt durch die technik von superkritischen antilösungsmittelnInfo
- Publication number
- ATE234341T1 ATE234341T1 AT00931057T AT00931057T ATE234341T1 AT E234341 T1 ATE234341 T1 AT E234341T1 AT 00931057 T AT00931057 T AT 00931057T AT 00931057 T AT00931057 T AT 00931057T AT E234341 T1 ATE234341 T1 AT E234341T1
- Authority
- AT
- Austria
- Prior art keywords
- hyaluronic acid
- produced
- technology
- dimensional structure
- acid derivative
- Prior art date
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical class CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 2
- 239000012296 anti-solvent Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000001556 precipitation Methods 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
Classifications
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F9/00—Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/28—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2201/00—Foams characterised by the foaming process
- C08J2201/04—Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
- C08J2201/054—Precipitating the polymer by adding a non-solvent or a different solvent
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2203/00—Foams characterized by the expanding agent
- C08J2203/08—Supercritical fluid
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Materials Engineering (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Textile Engineering (AREA)
- Materials For Medical Uses (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1999PD000071A IT1306644B1 (it) | 1999-04-08 | 1999-04-08 | Strutture tridimensionali comprendenti derivati dell'acido ialuronicoottenibili mediante la tecnica antisolvente supercritico. |
| PCT/EP2000/003081 WO2000061675A1 (en) | 1999-04-08 | 2000-04-06 | Three-dimensional structures containing hyaluronic acid derivatives obtained by the supercritical antisolvent technique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE234341T1 true ATE234341T1 (de) | 2003-03-15 |
Family
ID=11392548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00931057T ATE234341T1 (de) | 1999-04-08 | 2000-04-06 | Dreidimensionale struktur enthaltend hyaluronsäurederivat, hergestellt durch die technik von superkritischen antilösungsmitteln |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7087745B1 (enExample) |
| EP (1) | EP1169387B1 (enExample) |
| JP (1) | JP2002541888A (enExample) |
| AT (1) | ATE234341T1 (enExample) |
| AU (1) | AU765563B2 (enExample) |
| CA (1) | CA2369284C (enExample) |
| DE (1) | DE60001640T2 (enExample) |
| ES (1) | ES2194727T3 (enExample) |
| IT (1) | IT1306644B1 (enExample) |
| WO (1) | WO2000061675A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITPD20010032A1 (it) | 2001-02-09 | 2002-08-09 | Fidia Advanced Biopolymers Srl | Innesti ingegnerizzati per la riparazione di difetti osteocondrali |
| RU2220729C2 (ru) * | 2002-01-31 | 2004-01-10 | Общество с ограниченной ответственностью "Научный Центр системных исследований и технологий 2000" | Гелевая композиция, используемая в стоматологии |
| FR2850282B1 (fr) | 2003-01-27 | 2007-04-06 | Jerome Asius | Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation |
| ZA200507803B (en) * | 2003-04-04 | 2007-03-28 | Bayco Tech Ltd | Vascular stent |
| US8512730B2 (en) * | 2004-07-12 | 2013-08-20 | Isto Technologies, Inc. | Methods of tissue repair and compositions therefor |
| US8192759B2 (en) * | 2004-07-12 | 2012-06-05 | Isto Technologies, Inc. | Matrix made of polyester polymers entangled with hyaluronic polymers useful for supporting tissue repair |
| US8444968B2 (en) * | 2005-12-07 | 2013-05-21 | Isto Technologies, Inc. | Cartilage repair methods |
| ITPD20060219A1 (it) | 2006-05-31 | 2007-12-01 | Fidia Farmaceutici | Composizioni farmaceutiche contenenti acido ialuronico solfatato nel trattamento dell'osteoartrosi |
| JP5758797B2 (ja) | 2008-04-04 | 2015-08-05 | ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション | アルキル化半合成グリコサミノグリカンエーテルならびにその製造および使用方法 |
| EP2324064B1 (en) | 2008-09-02 | 2017-11-08 | Tautona Group LP | Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof |
| JP6062917B2 (ja) | 2011-03-23 | 2017-01-18 | ザ ユニバーシティ オブ ユタ リサーチ ファウンデイション | 泌尿器科の炎症の治療及び予防の方法 |
| US10245306B2 (en) | 2012-11-16 | 2019-04-02 | Isto Technologies Ii, Llc | Flexible tissue matrix and methods for joint repair |
| CZ2013913A3 (cs) * | 2013-11-21 | 2015-06-03 | Contipro Biotech S.R.O. | Objemný nanovlákenný materiál na bázi kyseliny hyaluronové, jejích solí nebo jejich derivátů, způsob jeho přípravy, způsob jeho modifikace, modifikovaný nanovlákenný materiál, nanovlákenný útvar a jejich použití |
| US10179191B2 (en) | 2014-10-09 | 2019-01-15 | Isto Technologies Ii, Llc | Flexible tissue matrix and methods for joint repair |
| CN105734604B (zh) * | 2016-03-03 | 2017-08-25 | 武汉大学 | 一种立体复合多糖凝胶及其电化学3d打印制备方法和应用 |
| WO2018053111A1 (en) | 2016-09-15 | 2018-03-22 | University Of Utah Research Foundation | In situ gelling compositions for the treatment or prevention of inflammation and tissue damage |
| CN111228653A (zh) | 2018-11-13 | 2020-06-05 | 格莱科米拉治疗公司 | 用电离辐射加强癌症治疗的方法 |
| JP2019104937A (ja) * | 2019-04-04 | 2019-06-27 | イビデン株式会社 | ヒアルロン酸及び／又はその塩の粉末 |
| JP2019104938A (ja) * | 2019-04-04 | 2019-06-27 | イビデン株式会社 | ヒアルロン酸及び／又はその塩の粉末 |
| CN110423291B (zh) * | 2019-09-06 | 2020-06-16 | 焦点生物医药有限公司 | 一种速溶透明质酸钠制备方法 |
| WO2025072953A1 (en) * | 2023-09-28 | 2025-04-03 | University Of Massachusetts | Composition for depolymerizing resins and methods of accomplishing the same |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7811306L (sv) | 1978-11-01 | 1980-05-02 | Rothman Gunnvor | Antikoagulationsmedel samt sett for dess framstellning |
| CH666897A5 (fr) | 1983-10-11 | 1988-08-31 | Fidia Spa | Fractions d'acide hyaluronique non inflammatoire, procedes et compositions pharmaceutiques. |
| US4851521A (en) * | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
| FR2584728B1 (fr) | 1985-07-12 | 1987-11-20 | Choay Sa | Procede de sulfatation de glycosaminoglycanes et de leurs fragments |
| IT1198449B (it) | 1986-10-13 | 1988-12-21 | F I D I Farmaceutici Italiani | Esteri di alcoli polivalenti di acido ialuronico |
| DK505588D0 (da) | 1988-02-26 | 1988-09-09 | Jesper Hamburger | Middel og anvendelse af samme |
| IT1219587B (it) | 1988-05-13 | 1990-05-18 | Fidia Farmaceutici | Polisaccaridi carbossiilici autoreticolati |
| IT1219942B (it) | 1988-05-13 | 1990-05-24 | Fidia Farmaceutici | Esteri polisaccaridici |
| IT1247175B (it) | 1991-04-19 | 1994-12-12 | Fidia Spa | Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico. |
| IT1254704B (it) * | 1991-12-18 | 1995-10-09 | Mini Ricerca Scient Tecnolog | Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico |
| IT1260148B (it) | 1992-04-17 | 1996-03-28 | Fidia Spa | Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo |
| ITPD940054A1 (it) | 1994-03-23 | 1995-09-23 | Fidia Advanced Biopolymers Srl | Polisaccaridi solfatati |
| EP0817620B1 (en) | 1995-03-28 | 2002-01-30 | Fidia Advanced Biopolymers, S.R.L. | Nanospheres comprising a biocompatible polysaccharide |
| US5833891A (en) | 1996-10-09 | 1998-11-10 | The University Of Kansas | Methods for a particle precipitation and coating using near-critical and supercritical antisolvents |
| IT1287698B1 (it) | 1996-08-29 | 1998-08-18 | Fidia Advanced Biopolymers Srl | Fili da sutura essenzialmente costituiti da derivati esterei dello acido ialuronico |
| DK0971961T3 (da) | 1997-04-04 | 2003-03-24 | Fidia Advanced Biopolymers Srl | N-sulfaterede hyaluronsyreforbindelser, derivater deraf og en fremgangsmåde til deres fremstilling |
-
1999
- 1999-04-08 IT IT1999PD000071A patent/IT1306644B1/it active
-
2000
- 2000-04-06 JP JP2000611610A patent/JP2002541888A/ja active Pending
- 2000-04-06 DE DE60001640T patent/DE60001640T2/de not_active Expired - Lifetime
- 2000-04-06 US US09/958,144 patent/US7087745B1/en not_active Expired - Fee Related
- 2000-04-06 AU AU49126/00A patent/AU765563B2/en not_active Ceased
- 2000-04-06 AT AT00931057T patent/ATE234341T1/de active
- 2000-04-06 CA CA002369284A patent/CA2369284C/en not_active Expired - Fee Related
- 2000-04-06 WO PCT/EP2000/003081 patent/WO2000061675A1/en not_active Ceased
- 2000-04-06 ES ES00931057T patent/ES2194727T3/es not_active Expired - Lifetime
- 2000-04-06 EP EP00931057A patent/EP1169387B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000061675A1 (en) | 2000-10-19 |
| DE60001640T2 (de) | 2004-03-25 |
| JP2002541888A (ja) | 2002-12-10 |
| EP1169387A1 (en) | 2002-01-09 |
| AU765563B2 (en) | 2003-09-25 |
| EP1169387B1 (en) | 2003-03-12 |
| CA2369284A1 (en) | 2000-10-19 |
| AU4912600A (en) | 2000-11-14 |
| ES2194727T3 (es) | 2003-12-01 |
| DE60001640D1 (de) | 2003-04-17 |
| CA2369284C (en) | 2010-01-12 |
| ITPD990071A1 (it) | 2000-10-08 |
| US7087745B1 (en) | 2006-08-08 |
| IT1306644B1 (it) | 2001-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE234341T1 (de) | Dreidimensionale struktur enthaltend hyaluronsäurederivat, hergestellt durch die technik von superkritischen antilösungsmitteln | |
| PT1144459E (pt) | Acidos hialuronicos reticulados e as suas utilizacoes em medicina | |
| CY1107838T1 (el) | Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων | |
| DE69618938D1 (de) | Nanosphären mit einem biokompatiblen polysaccharid | |
| WO2001041800A3 (en) | Compositions and methods for stabilizing biological molecules upon lyophilization | |
| NO20003698L (no) | Orale sammensetninger | |
| NL300389I1 (nl) | Thiofeensulfonamiden die bruikbaar zijn als carbo-anhydraseremmers. | |
| NO20050807L (no) | Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser | |
| MXPA05008406A (es) | Compuestos de amida tri(ciclo)-sustituida. | |
| DE60118547D1 (de) | Pharmazeutische zusammensetzung zur behandlung von kolorektalem krebs welche thalidomid und irinotecan enthält | |
| NO20084187L (no) | Medikamenter og proteiner | |
| BR0213298A (pt) | formulações com alta concentração de proteìna e processo de fabricação | |
| HUP0105103A2 (hu) | Tumornekrózis faktor-antagonisták és alkalmazásuk endometriózisban | |
| ATE139226T1 (de) | Aminosulfonylharnstoff-acat-inhibitoren | |
| DK0479093T3 (da) | Oligosaccharidderivater og deres anvendelse som lægemidler | |
| CA2369275A1 (en) | Process for the preparation of autocrosslinked compounds of hyaluronic acid and the derivatives thereof by the supercritical antisolvent technique | |
| ATE344223T1 (de) | Vitamin d-analoge | |
| ATE245974T1 (de) | Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung | |
| NO20025461L (no) | Nye formuleringer av <alfa>-(2,4-disulfofenyl)-N-tert- butylnitron | |
| ATE259223T1 (de) | Pharmazeutische zusammensetzung die einen no donor enthält und dessen therapeutische anwendung | |
| DK1644484T3 (da) | Autologe selv-toleransinducerende celler af monocytisk oprindelse og deres anvendelse i lægemidler | |
| ATE254469T1 (de) | Verfahren zur verminderung der renalen aufnahme von antikörperfragmenten | |
| PT711163E (pt) | Utilizacao de benzidamina no tratamento de estados patologicos provocados por tnf | |
| ATE404519T1 (de) | Hyperforinderivate, ihre verwendung sowie diese enthaltende zubereitungen | |
| HU9300349D0 (en) | Method for producing dibenzo- or benzo-pyrido-cyclohepta-piperidine derivatives or piperidylidene or piperazine derivatives thereof as well as pharmaceutical preparatives contqining them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1169387 Country of ref document: EP |